Annexon, Inc.
ANNX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001528115
In the last 90 days, Annexon, Inc. insiders filed 1 open-market purchase and 0 sales; 216 institutions reported holding it in 13F filings for Q2 2026, worth $1.02B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Annexon, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 93
- −1 vs. Q2 2023
- Shares held
- 53.6M
- +1.33M (+2.5%) vs. Q2 2023
- Total value
- $126.0M
- −$57.3M (−31.3%) vs. Q2 2023
- New holders
- 14
- 30 more added
- Sold out
- 15
- 28 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 216 | $1.02B |
| Q1 2026 | 217 | $863.7M |
| Q4 2025 | 168 | $687.2M |
| Q3 2025 | 144 | $309.2M |
| Q2 2025 | 129 | $238.7M |
| Q1 2025 | 148 | $192.1M |
| Q4 2024 | 153 | $574.6M |
| Q3 2024 | 142 | $651.8M |
| Q2 2024 | 140 | $526.9M |
| Q1 2024 | 127 | $679.4M |
| Q4 2023 | 99 | $365.7M |
| Q3 2023 | 93 | $126.0M |
| Q2 2023 | 95 | $190.0M |
| Q1 2023 | 100 | $207.6M |
| Q4 2022 | 84 | $243.3M |
| Q3 2022 | 72 | $292.3M |
| Q2 2022 | 78 | $144.9M |
| Q1 2022 | 100 | $105.9M |
| Q4 2021 | 97 | $445.7M |
| Q3 2021 | 82 | $708.6M |
| Q2 2021 | 74 | $873.7M |
| Q1 2021 | 72 | $1.04B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Annexon, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −27,695−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −24,368−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −21,230−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −16,841−100.0% | Sold out |
| Values First Advisors, Inc. | 0 | $0 | 0.00% | −12,309−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −11,078−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −9,373−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,525−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |